Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maternal Serum Pentraxin 3 in Early Pregnancy to Predict Gestational Diabetes Mellitus

NCT03563638 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.

NCT NCT03563638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03563638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maternal Serum Pentraxin 3 in Early Pregnancy to Predict Gestational Diabetes Mellitus
Lead sponsor
Shanghai First Maternity and Infant Hospital
Phase
Observational
Overall status
Completed
Start date
October 1, 2015
Completion date
December 1, 2015
Enrollment
824 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy complications affecting fetus (diagnosis)